Stoke Therapeutics Inc. (STOK) Files $400M Mixed Shelf
- Stocks extend bear market bounce as inflation angst eases
- Oil prices slip ahead of G7 talks on new Russian sanctions
- Coinbase Downgraded to Sell at Goldman on Further Downside Risk, Robinhood Upgraded to Neutral on Better Risk-Reward
- Dollar struggles as big rate hike bets cool
- JP Morgan's Kolanovic Predicts No Recession and Next Week's Rebalancing Could Drive Stocks Up 7%
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Stoke Therapeutics Inc. (NASDAQ: STOK) has filed $400,000,000 mixed shelf of: Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerberus Cyber Sentinel Corp (CISO) Files $300M Mixed Shelf
- Waldencast Acquisition Corp (WALD) Enters $225M Term Loan and Revolving Credit Facilities
- Swvl Holdings Corp (SWVL) Announces 102.94M Share Offering by Selling Stockholders
Create E-mail Alert Related CategoriesCorporate News, Equity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!